Customize your JAMA Network experience by selecting one or more topics from the list below.
In the article titled “Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial,” published online January 21, 2021, and also in the March 2021 issue of JAMA Oncology,1 there was an error in the reported frequency of fluorouracil dosing in the Intervention section of the Visual Abstract. The correct dosing frequency is every 2 weeks. The article has been corrected online.
Error in Visual Abstract. JAMA Oncol. Published online September 23, 2021. doi:10.1001/jamaoncol.2021.5278
Oncology in JAMA: Read the Latest